UAE approves use of drug to combat ‘silent killer’ high cholesterol
The UAE has approved the use of a daily pill to treat high cholesterol, a silent killer putting…
Five common medications that make it harder to cope in a heatwave
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Colorado pharmacy board sues Denver restaurant for selling antibiotics
The Colorado State Board of Pharmacy is suing a restaurant and bakery in Denver’s Gateway neighborhood for selling antibiotics…
SAHPRA Recalls Specific ENO, Aqueous Cream and Nintedanib Batches
South Africans are being urged to check certain healthcare products following the recall of specific batches of ENO…
Indonesia develops frankincense oil for premium perfumes
Jakarta (ANTARA) – Indonesia’s National Research and Innovation Agency (BRIN) has developed high-grade essential oil from indigenous frankincense…
GLP-1 drugs like Ozempic might help clear Alzheimer’s disease plaques, new review suggests
A recent review published in Molecular and Cellular Neuroscience suggests that a popular class of diabetes and weight-loss…
For GLP-1 users, the in-store clothes shopping trip is back
NEW YORK — Nora Nye, 58, is refreshing her wardrobe as she sizes down for the first time…
Symptoms improved within first week: FDA approves new ADHD drug for children, adults
Developed by Japanese pharmaceutical company Otsuka, Simtriyo contains the active ingredient centanafadine and is administered as an extended-release…
These 6 Popular Peptides May Soon Be Easier to Get — Here’s What That Means
A U.S. Food and Drug Administration (FDA) advisory committee recently recommended loosening restrictions on certain popular peptides — drugs marketed…
, DrugsControl Media Services
, DrugsControl Media Services DrugsControl Media Services DrugsControl.org News Detail » » » » » » » »…
FDA Recalls Prescription Blood Thinner Dabigatran Nationwide
2 min read Key Points The FDA has issued a report warning the public that some dabigatran etexilate…
FDA Approves ‘First-in-Class’ NDSRI for ADHD in Adults and Children
Federal regulators have approved a new medication to help manage attention deficit hyperactivity disorder (ADHD). SIMTRIYO is a…